PATENT CLAIM ANALYSIS

Application Number: 15915637
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "093710"]

Abstract:
Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.

Claim (Index 3):
The method of any one of  claims 1  to  2 , wherein the subject has cardiomyopathy.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.47059
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11921676', '14384910', '11256685', '11685674', '11330033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.738955884176169
- 35 USC 102 Novelty (BERT): 0.5523357359747317
- Combined Prediction Score: 0.7202938693560252
- Mean Citation Score: 322.81307400000014
- Max Citation Score: 416.39224
- Similarity Product: 272.3500280936432

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test